hims glp 1 results Inc Hims & Hers data shows
Description
[DOI] [PubMed] [Google Scholar] 17.Iwai T., Ito S., Tanimitsu K., Udagawa S., Oka J.-I
Tirzepatide came off the FDA shortage list in December 2024 (enforcement discretion ended March 2025)
PloS One 8 (2), e55382
Van Gaal L, Souhami E, Zhou T, Aronson R
The weekly GLP-1 medications are unusual in the peptide world because of their engineered long half-lives
Today, however, there are more than 50 FDA-approved biosimilars available as alternatives to original biologic drugs
